1 |
(2)-epigallocatechin-3-gallate (egcg) |
Epigallocatechin |
- |
- |
- |
008 1件: 8 💬 |
2 |
20 mg bid of pf-02545920 |
- |
- |
- |
- |
008 1件: 8 💬 |
3 |
20mg daily citalopram |
Citalopram |
2件: D00822 D00822, D07704 D07704 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
008 1件: 8 💬 |
4 |
5-chloro-1,2-dihydro-n-ethyl-4-hydroxy-1-methyl-2-oxo-n-phenyl-3-quinolinecarboxamide sodium |
- |
- |
- |
- |
008 1件: 8 💬 |
5 |
[123i]mni-420 |
- |
- |
- |
- |
006 2件: 6 , 8 💬 |
6 |
[18f]fpeb |
- |
- |
- |
- |
006 3件: 6 , 8 , 206 💬 |
7 |
Acr16 |
- |
- |
- |
- |
008 1件: 8 💬 |
8 |
Acr16 10 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
9 |
Acr16 22.5 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
10 |
Acr16 45 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
11 |
Acr16 hydrochloride, asp2314 hydrochloride, fr310826 |
- |
- |
- |
- |
008 1件: 8 💬 |
12 |
Afq056 |
- |
- |
- |
- |
006 3件: 6 , 8 , 206 💬 |
13 |
Alprazolam |
Alprazolam |
1件: D00225 D00225 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
008 1件: 8 💬 |
14 |
Amantadine |
Amantadine |
2件: D00777 D00777, D07441 D07441 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 4件: 6 , 8 , 13, 127 💬 |
15 |
Anti-parkinson medication |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 8 , 17 💬 |
16 |
Anx005 |
- |
- |
- |
- |
002 3件: 2 , 8 , 61 💬 |
17 |
Atomoxetine |
Atomoxetine |
2件: D02574 D02574, D07473 D07473 💬 |
SLC6A2 1件: SLC6A2 💬 |
Synaptic vesicle cycle 1件: Synaptic vesicle cycle |
006 3件: 6 , 8 , 13 💬 |
18 |
Autologous stem cell |
- |
- |
- |
- |
008 1件: 8 💬 |
19 |
Bevantolol |
Bevantolol |
- |
- |
- |
008 1件: 8 💬 |
20 |
Bevantolol hydrochloride |
Bevantolol |
- |
- |
- |
008 1件: 8 💬 |
21 |
Biotin |
Biotin |
1件: D00029 D00029 💬 |
- |
- |
002 5件: 2 , 8 , 10, 13, 20 💬 |
22 |
Blood sample |
- |
- |
- |
- |
008 13件: 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
23 |
Bn82451b |
- |
- |
- |
- |
008 1件: 8 💬 |
24 |
Bn8251b |
- |
- |
- |
- |
008 1件: 8 💬 |
25 |
Bupropion |
Bupropion |
3件: D00817 D00817, D07591 D07591, D07938 D07938 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
008 5件: 8 , 18, 21, 96, 171 💬 |
26 |
Calvan® 100 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
27 |
Cannabidiol |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 17件: 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
28 |
Cbd |
- |
- |
- |
- |
002 11件: 2 , 6 , 8 , 13, 46, 140, 144, 145, 156, 158, 206 💬 |
29 |
Cellavita hd higher dose |
- |
- |
- |
- |
008 1件: 8 💬 |
30 |
Cellavita hd lower dose |
- |
- |
- |
- |
008 1件: 8 💬 |
31 |
Cellavita-hd |
- |
- |
- |
- |
008 1件: 8 💬 |
32 |
Citalopram |
Citalopram |
2件: D00822 D00822, D07704 D07704 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 6件: 6 , 8 , 13, 18, 46, 127 💬 |
33 |
Ckd-504 |
- |
- |
- |
- |
008 1件: 8 💬 |
34 |
Coenzyme q10 |
Ubidecarenone |
1件: D01065 D01065 💬 |
- |
- |
002 12件: 2 , 5 , 6 , 8 , 10, 18, 46, 57, 113, 193, 214, 215 💬 |
35 |
Coq10 |
- |
- |
- |
- |
005 3件: 5 , 6 , 8 💬 |
36 |
Creatine |
Creatine |
- |
- |
- |
001 12件: 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
37 |
Creatine monohydrate |
Creatine |
- |
- |
- |
002 4件: 2 , 8 , 113, 156 💬 |
38 |
Cystagon |
- |
- |
- |
- |
008 3件: 8 , 19, 299 💬 |
39 |
Cysteamine |
Cysteamine |
2件: D03634 D03634, D03635 D03635 💬 |
- |
- |
008 4件: 8 , 19, 21, 299 💬 |
40 |
Cysteamine bitartrate |
Cysteamine |
2件: D03634 D03634, D03635 D03635 💬 |
- |
- |
008 4件: 8 , 19, 21, 299 💬 |
41 |
Delta-9-tetrahydrocannabinol |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 2件: 8 , 13 💬 |
42 |
Delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) |
Cannabidiol |
2件: D00306 D00306, D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 1件: 8 💬 |
43 |
Deutetrabenazine |
Deutetrabenazine |
1件: D10701 D10701 💬 |
SLC18A2 1件: SLC18A2 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 1件: 8 💬 |
44 |
Deutetrabenazine oral tablet [austedo] |
Deutetrabenazine |
1件: D10701 D10701 💬 |
SLC18A2 1件: SLC18A2 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 1件: 8 💬 |
45 |
Device: biostamp npoint device |
- |
- |
- |
- |
008 1件: 8 💬 |
46 |
Device: deep brain stimulation |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 8 , 17 💬 |
47 |
Dextromethorphan |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
48 |
Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg) |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
008 1件: 8 💬 |
49 |
Digoxin |
Digoxin |
1件: D00298 D00298 💬 |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 |
Adrenergic signaling in cardiomyocytes 18件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
008 3件: 8 , 46, 210 💬 |
50 |
Dimebon |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
51 |
Dimebon (latrepirdine) |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
52 |
Dimebon + dextromethorphan |
Dextromethorphan |
4件: D00848 D00848, D03742 D03742, D03744 D03744, D09917 D09917 💬 |
ACHE 7件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
53 |
Dimebon + ketoconazole |
Ketoconazole |
2件: D00351 D00351, D09917 D09917 💬 |
ACHE 7件: ACHE, CYP17A1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 28件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Pathways of neurodegeneration - multiple diseases, Prion disease, Prolactin signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Steroid hormone biosynthesis, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
54 |
Dimebon + omeprazole |
Latrepirdine |
5件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261, D09917 D09917 💬 |
ACHE 8件: ACHE, ATP4A, ATP4B, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 26件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
55 |
Dimebon alone |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
56 |
Dimebon dihydrochloride |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
57 |
Dimebon ir |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
58 |
Dimebon ir tablet |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
59 |
Dimebon mr1 |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
60 |
Dimebon mr2 |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
61 |
Dimebon mr3 |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
62 |
Dimebon mr4 |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
63 |
Dimebon transdermal |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
64 |
Divalproex |
- |
- |
- |
- |
008 1件: 8 💬 |
65 |
Dm |
- |
- |
- |
- |
006 2件: 6 , 8 💬 |
66 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
006 9件: 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
67 |
Epa |
- |
- |
- |
- |
008 6件: 8 , 46, 48, 49, 113, 301 💬 |
68 |
Epigallocatechin |
Epigallocatechin |
- |
- |
- |
008 5件: 8 , 13, 28, 85, 113 💬 |
69 |
Ethyl icosapent |
Icosapent |
1件: D08061 D08061 💬 |
- |
- |
008 1件: 8 💬 |
70 |
Ethyl-epa |
Icosapent ethyl |
1件: D01892 D01892 💬 |
- |
- |
008 1件: 8 💬 |
71 |
Ethyl-epa (miraxion™) |
Icosapent ethyl |
1件: D01892 D01892 💬 |
- |
- |
008 1件: 8 💬 |
72 |
Ethyl-icosapent |
Icosapent |
1件: D08061 D08061 💬 |
- |
- |
008 1件: 8 💬 |
73 |
Fenofibrate |
Fenofibrate |
1件: D00565 D00565 💬 |
PPARA 1件: PPARA 💬 |
Adipocytokine signaling pathway 8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
008 5件: 8 , 79, 93, 94, 265 💬 |
74 |
Graft intracerebral of foetal neurons |
- |
- |
- |
- |
008 1件: 8 💬 |
75 |
Gsk356278 |
- |
- |
- |
- |
008 1件: 8 💬 |
76 |
Haloperidol |
Haloperidol |
2件: D00136 D00136, D01898 D01898 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
008 1件: 8 💬 |
77 |
High doses of thiamine y biotin |
Biotin |
2件: D00029 D00029, D08580 D08580 💬 |
- |
- |
008 1件: 8 💬 |
78 |
Hyperium |
Rilmenidine |
1件: D08482 D08482 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
008 1件: 8 💬 |
79 |
Icosapent |
Icosapent |
1件: D08061 D08061 💬 |
- |
- |
008 1件: 8 💬 |
80 |
Isis 443139 10 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
81 |
Isis 443139 120 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
82 |
Isis 443139 30 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
83 |
Isis 443139 60 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
84 |
Isis 443139 90 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
85 |
Ketoconazole |
Ketoconazole |
1件: D00351 D00351 💬 |
CYP17A1 1件: CYP17A1 💬 |
Cortisol synthesis and secretion 6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis |
008 3件: 8 , 13, 75 💬 |
86 |
Laquinimod |
Laquinimod |
- |
- |
- |
008 4件: 8 , 13, 49, 96 💬 |
87 |
Laquinimod capsules 0.5 mg |
Laquinimod |
- |
- |
- |
008 2件: 8 , 96 💬 |
88 |
Latrepirdine |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
89 |
Lax-101 |
LAX-101 |
- |
- |
- |
008 1件: 8 💬 |
90 |
Lithium |
- |
- |
- |
- |
002 5件: 2 , 5 , 6 , 7 , 8 💬 |
91 |
Melatonin |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 11件: 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
92 |
Memantine |
Memantine |
2件: D04905 D04905, D08174 D08174 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 7件: 2 , 6 , 8 , 13, 49, 127, 205 💬 |
93 |
Minocycline |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
002 13件: 2 , 6 , 8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
94 |
Moderate doses of thiamine y biotin |
Biotin |
2件: D00029 D00029, D08580 D08580 💬 |
- |
- |
008 1件: 8 💬 |
95 |
N.a. |
- |
- |
- |
- |
003 10件: 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
96 |
Neflamapimod |
Neflamapimod |
1件: D10959 D10959 💬 |
MAPK11 4件: MAPK11, MAPK12, MAPK13, MAPK14 💬 |
AGE-RAGE signaling pathway in diabetic complications 58件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection |
008 1件: 8 💬 |
97 |
Nilotinib |
Nilotinib |
1件: D08953 D08953 💬 |
ABL1 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 5件: 6 , 8 , 34, 51, 86 💬 |
98 |
Nilotinib 150 mg |
Nilotinib |
1件: D08953 D08953 💬 |
ABL1 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
008 1件: 8 💬 |
99 |
Olanzapine |
Olanzapine |
2件: D00454 D00454, D06623 D06623 💬 |
ADRA1A 11件: ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6 💬 |
AMPK signaling pathway 16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 2件: 2 , 8 💬 |
100 |
Omeprazole |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 16件: 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
101 |
Oms643762 |
- |
- |
- |
- |
008 1件: 8 💬 |
102 |
Osu6162 similar to (-)-osu 6162 |
- |
- |
- |
- |
006 2件: 6 , 8 💬 |
103 |
Other: 31-phosphorus rmn spectroscopy |
Phosphorus |
- |
- |
- |
008 1件: 8 💬 |
104 |
Pbf-999 |
- |
- |
- |
- |
008 1件: 8 💬 |
105 |
Pbf-999 / 160 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
106 |
Pbf-999 / 320 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
107 |
Pbt2 |
- |
- |
- |
- |
008 1件: 8 💬 |
108 |
Pf-02545920 |
- |
- |
- |
- |
008 1件: 8 💬 |
109 |
Phenylbutyrate |
Phenylbutyric acid |
1件: D05868 D05868 💬 |
- |
- |
002 11件: 2 , 3 , 6 , 8 , 15, 93, 94, 244, 251, 297, 299 💬 |
110 |
Phosphorus |
Phosphorus |
- |
- |
- |
008 1件: 8 💬 |
111 |
Pl101 |
- |
- |
- |
- |
008 1件: 8 💬 |
112 |
Pridiopidine |
- |
- |
- |
- |
008 1件: 8 💬 |
113 |
Pridopidina |
- |
- |
- |
- |
008 1件: 8 💬 |
114 |
Pridopidine |
Pridopidine |
1件: D09953 D09953 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 3件: 2 , 6 , 8 💬 |
115 |
Pridopidine (90 mg) |
Pridopidine |
1件: D09953 D09953 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
008 1件: 8 💬 |
116 |
Pridopidine hydrochloride |
Pridopidine |
1件: D09953 D09953 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
008 1件: 8 💬 |
117 |
Quinidine |
Quinidine |
4件: D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
002 3件: 2 , 8 , 13 💬 |
118 |
Ramelteon |
Ramelteon |
1件: D02689 D02689 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 3件: 6 , 8 , 46 💬 |
119 |
Resveratrol |
Resveratrol |
- |
- |
- |
002 6件: 2 , 8 , 18, 89, 113, 299 💬 |
120 |
Rg6042, formerly isis 443139, ionis-httrx |
- |
- |
- |
- |
008 1件: 8 💬 |
121 |
Rilmenidine |
Rilmenidine |
1件: D08482 D08482 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
008 1件: 8 💬 |
122 |
Riluzole |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 8件: 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
123 |
Risperidone |
Risperidone |
1件: D00426 D00426 💬 |
DRD2 2件: DRD2, HTR2A 💬 |
Alcoholism 11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway |
008 5件: 8 , 156, 179, 187, 206 💬 |
124 |
Ro 723-4292/f02 |
- |
- |
- |
- |
008 1件: 8 💬 |
125 |
Ro7234292 |
- |
- |
- |
- |
008 1件: 8 💬 |
126 |
Ro7234292 (rg6042) |
- |
- |
- |
- |
008 1件: 8 💬 |
127 |
Rolipram |
Rolipram |
1件: D01783 D01783 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
008 2件: 8 , 13 💬 |
128 |
Rp 103 |
- |
- |
- |
- |
008 2件: 8 , 19 💬 |
129 |
Rp103 |
- |
- |
- |
- |
008 2件: 8 , 19 💬 |
130 |
Sage-718 |
- |
- |
- |
- |
006 2件: 6 , 8 💬 |
131 |
Sbt-020 |
- |
- |
- |
- |
008 1件: 8 💬 |
132 |
Sd-809 |
- |
- |
- |
- |
008 1件: 8 💬 |
133 |
Selisistat |
Selisistat |
- |
- |
- |
008 1件: 8 💬 |
134 |
Sen0014196 |
- |
- |
- |
- |
008 1件: 8 💬 |
135 |
Sen0014196 (high dose) |
- |
- |
- |
- |
008 1件: 8 💬 |
136 |
Sen0014196 (low dose) |
- |
- |
- |
- |
008 1件: 8 💬 |
137 |
Sodium phenylbutyrate |
Phenylbutyric acid |
1件: D05868 D05868 💬 |
- |
- |
002 4件: 2 , 3 , 8 , 251 💬 |
138 |
Som3355 100mg bid |
- |
- |
- |
- |
008 1件: 8 💬 |
139 |
Som3355 200mg bid |
- |
- |
- |
- |
008 1件: 8 💬 |
140 |
Srx246 |
- |
- |
- |
- |
008 1件: 8 💬 |
141 |
Ss-20 |
- |
- |
- |
- |
008 1件: 8 💬 |
142 |
Tetrabenazine |
Tetrabenazine |
1件: D08575 D08575 💬 |
SLC18A2 1件: SLC18A2 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 1件: 8 💬 |
143 |
Tetrabenazine withdrawal |
Tetrabenazine |
1件: D08575 D08575 💬 |
SLC18A2 1件: SLC18A2 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 1件: 8 💬 |
144 |
Tetrahydrocannabinol |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 3件: 8 , 13, 298 💬 |
145 |
Thc |
- |
- |
- |
- |
008 4件: 8 , 13, 46, 96 💬 |
146 |
Thiamine |
Thiamine |
1件: D08580 D08580 💬 |
- |
- |
008 3件: 8 , 13, 265 💬 |
147 |
Tiapridal |
- |
- |
- |
- |
008 1件: 8 💬 |
148 |
Tominersen |
- |
- |
- |
- |
008 1件: 8 💬 |
149 |
Triheptanoin |
Triheptanoin |
1件: D11465 D11465 💬 |
- |
- |
002 9件: 2 , 8 , 149, 156, 248, 256, 257, 317, 324 💬 |
150 |
Triheptanoin 1g/kg/day |
Triheptanoin |
1件: D11465 D11465 💬 |
- |
- |
008 1件: 8 💬 |
151 |
Triheptanoin oil |
Triheptanoin |
1件: D11465 D11465 💬 |
- |
- |
008 1件: 8 💬 |
152 |
Tv-5600 |
- |
- |
- |
- |
008 3件: 8 , 13, 96 💬 |
153 |
Tv-7820 |
- |
- |
- |
- |
008 1件: 8 💬 |
154 |
Ubiquinol |
Ubiquinol |
- |
- |
- |
006 3件: 6 , 8 , 17 💬 |
155 |
Ursodiol |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
008 6件: 8 , 20, 93, 97, 234, 299 💬 |
156 |
Ux007 |
- |
- |
- |
- |
008 4件: 8 , 248, 256, 257 💬 |
157 |
Valbenazine |
Valbenazine |
1件: D10675 D10675 💬 |
SLC18A2 1件: SLC18A2 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 1件: 8 💬 |
158 |
Vx-745 |
- |
- |
- |
- |
008 1件: 8 💬 |
159 |
Vx15/2503 |
- |
- |
- |
- |
008 2件: 8 , 13 💬 |
160 |
Warfarin |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
161 |
Wve-120101 |
- |
- |
- |
- |
008 1件: 8 💬 |
162 |
Wve-120102 |
- |
- |
- |
- |
008 1件: 8 💬 |
163 |
Xenazine |
- |
- |
- |
- |
008 1件: 8 💬 |
164 |
Zoloft |
- |
- |
- |
- |
008 1件: 8 💬 |